New York bills · 2025 Regular Session
New York A 2289
Enacts the manufacturer disclosure and transparency act
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Emily Gallagher (Democratic)
Cosponsors (27)
- Albert A. Stirpe (Democratic)
- Phara Souffrant Forrest (Democratic)
- Steve Stern (Democratic)
- Jessica Gonzalez-Rojas (Democratic/Working Families)
- Jo Anne Simon (Democratic)
- MaryJane Shimsky (Democratic/Working Families)
- William Colton (Democratic)
- Karines Reyes (Democratic)
- Tony Simone (Democratic)
- Steven Raga (Democratic)
- Sarahana Shrestha (Democratic/Working Families)
- Rebecca Seawright (Democratic)
- Philip Ramos (Democratic)
- Linda Rosenthal (Democratic)
- Maritza Davila (Democratic)
- Sarah Clark (Democratic/Working Families)
- Donna Lupardo (Democratic)
- Keith Brown (Republican/Conservative/Independence)
- Harvey Epstein
- Angelo Santabarbara (Democratic)
- Gabriella Romero (Democratic/Working Families)
- Anna Kelles (Democratic/Working Families)
- Jonathan Jacobson (Democratic)
- Micah Lasher (Democratic)
- Judy Griffin (Democratic)
- Rebecca Kassay (Democratic)
- Diana Moreno (Democratic/Working Families)
Summary
Official abstract published by the New York legislature
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 7, 2026 · House
REFERRED TO CONSUMER AFFAIRS AND PROTECTION - May 22, 2025 · House
PRINT NUMBER 2289A - May 22, 2025 · House
AMEND AND RECOMMIT TO CONSUMER AFFAIRS AND PROTECTION - Jan 16, 2025 · House
REFERRED TO CONSUMER AFFAIRS AND PROTECTION